Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in End-Stage Renal Disease on Hemodialysis: A Meta-Analysis of Randomized Control Trials

被引：6

作者：

Faisaluddin, Mohammed ^{[1
]}

Alwifati, Nader ^{[1
]}

Naeem, Nauman ^{[1
]}

Balasubramanian, Senthil ^{[2
]}

Narasimhan, Bharat ^{[3
]}

Iqbal, Uzma ^{[4
]}

Dani, Sourbha S. ^{[5
]}

机构：

[1] Rochester Gen Hosp, Dept Internal Med, Rochester, NY USA

[2] NorthShore Univ Hlth Syst Metro Chicago, Div Cardiovasc Med, Evanston, IL USA

[3] Houston Methodist Hosp, Dept Cardiol, Houston, TX USA

[4] Rochester Gen Hosp, Dept Cardiovasc Med, New York, NY USA

[5] Lahey Hosp & Med Ctr, Dept Cardiovasc Med, Dept Med, Burlington, MA 01805 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2023年 / 206卷

关键词：

atrial fibrillation; anticoagulation; DOAC; NOAC; coumadin; warfarin; major; bleeding; APIXABAN;

D O I：

10.1016/j.amjcard.2023.08.116

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

End-stage renal disease (ESRD) and atrial fibrillation (AF) are commonly encountered, have recommended apixaban across all the spectrums of renal impairment, including lege of Cardiology/Heart Rhythm Society updated guidelines have suggested careful consideration of reduced dose of direct oral anticoagulants (DOACs) in patients with with AF with ESRD and HD is variable. This study aimed to perform a study-level metaanalysis to evaluate the effectiveness and safety of warfarin and DOACs in patients with AF who require dialysis. (c) 2023 Elsevier Inc. All rights reserved. (Am J Cardiol 2023;206:309-311)

引用

页码：309 / 311

页数：3

共 10 条

[1] Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial [J].

De Vriese, An S. ;

Caluwe, Rogier ;

Van Der Meersch, Hans ;

De Boeck, Koen ;

De Bacquer, Dirk .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (06) :1474-1483

[2] Dose-Finding Study of Rivaroxaban in Hemodialysis Patients [J].

De Vriese, An S. ;

Caluwe, Rogier ;

Bailleul, Els ;

De Bacquer, Dirk ;

Borrey, Danielle ;

Van Vlem, Bruno ;

Vandecasteele, Stefaan J. ;

Emmerechts, Jan .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) :91-98

[3]

January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI [10.1016/j.jacc.2019.01.011, 10.1161/CIR.0000000000000665]

[4] Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients [J].

Mavrakanas, Thomas A. ;

Samer, Caroline F. ;

Nessim, Sharon J. ;

Frisch, Gershon ;

Lipman, Mark L. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (07) :2241-2248

[5] Impact of Chronic Kidney Disease on Risk of Incident Atrial Fibrillation and Subsequent Survival in Medicare Patients [J].

Nelson, Sarah E. ;

Shroff, Gautam R. ;

Li, Shuling ;

Herzog, Charles A. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (04)

[6] Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial [J].

Pokorney, Sean D. ;

Chertow, Glenn M. ;

Al-Khalidi, Hussein R. ;

Gallup, Dianne ;

Dignacco, Pat ;

Mussina, Kurt ;

Bansal, Nisha ;

Gadegbeku, Crystal A. ;

Garcia, David A. ;

Garonzik, Samira ;

Lopes, Renato D. ;

Mahaffey, Kenneth W. ;

Matsuda, Kelly ;

Middleton, John P. ;

Rymer, Jennifer A. ;

Sands, George H. ;

Thadhani, Ravi ;

Thomas, Kevin L. ;

Washam, Jeffrey B. ;

Winkelmayer, Wolfgang C. ;

Granger, Christopher B. .

CIRCULATION, 2022, 146 (23) :1735-1745

[7] A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study [J].

Reinecke, Holger ;

Engelbertz, Christiane ;

Bauersachs, Rupert ;

Breithardt, Gunter ;

Echterhoff, Hans-Herbert ;

Gerss, Joachim ;

Haeusler, Karl Georg ;

Hewing, Bernd ;

Hoyer, Joachim ;

Juergensmeyer, Sabine ;

Klingenheben, Thomas ;

Knapp, Guido ;

Rump, Lars Christian ;

Schmidt-Guertler, Hans ;

Wanner, Christoph ;

Kirchhof, Paulus ;

Goerlich, Dennis .

CIRCULATION, 2023, 147 (04) :296-309

[8] Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States [J].

Siontis, Konstantinos C. ;

Zhang, Xiaosong ;

Eckard, Ashley ;

Bhave, Nicole ;

Schaubel, Douglas E. ;

He, Kevin ;

Tilea, Anca ;

Stack, Austin G. ;

Balkrishnan, Rajesh ;

Yao, Xiaoxi ;

Noseworthy, Peter A. ;

Shah, Nilay D. ;

Saran, Rajiv ;

Nallamothu, Brahmajee K. .

CIRCULATION, 2018, 138 (15) :1519-1529

[9] The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation [J].

Steffel, Jan ;

Verhamme, Peter ;

Potpara, Tatjana S. ;

Albaladejo, Pierre ;

Antz, Matthias ;

Desteghe, Lien ;

Haeusler, Kart Georg ;

Oldgren, Jonas ;

Reinecke, Holger ;

Roldan-Schilling, Vanessa ;

Rowell, Nigel ;

Sinnaeve, Peter ;

Collins, Ronan ;

Camm, A. John ;

Heidbulchel, Hein .

EUROPEAN HEART JOURNAL, 2018, 39 (16) :1330-1393

[10] The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients [J].

Wetmore, James B. ;

Mahnken, Jonathan D. ;

Rigler, Sally K. ;

Ellerbeck, Edward F. ;

Mukhopadhyay, Purna ;

Spertus, John A. ;

Hou, Qingjiang ;

Shireman, Theresa I. .

KIDNEY INTERNATIONAL, 2012, 81 (05) :469-476

← 1 →